This is Why There is a Need for Advanced Cell Isolation Techniques after COVID19 Impact


Posted July 4, 2022 by vmack2187

Stem Cell Network (SCN) is providing up to USD 500,000 in funding to support rapid response research that uses a stem cell or regenerative medicine approach for addressing COVID-19.
 
Overview of This Study:

This study involved four major activities in estimating the current size of the cell isolation market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate segments and subsegments' market size.

COVID-19 Impact on Cell Isolation Market:

COVID-19 is an infectious disease caused by the most recently discovered novel coronavirus. Largely unknown before the outbreak began in Wuhan (China) in December 2019, COVID-19 has moved from a regional crisis to a global pandemic in just a matter of a few weeks. The World Health Organization (WHO) declared COVID-19 as a pandemic on March 11, 2020.

Currently, various organizations are supporting the use of stem cells or regenerative medicine for vaccine development.

The governing board of the California Institute for Regenerative Medicine (CIRM) approved USD 5 million in funding for peer-reviewed regenerative medicine and stem cell research that could quickly advance treatments for COVID-19.

Stem Cell Network (SCN) is providing up to USD 500,000 in funding to support rapid response research that uses a stem cell or regenerative medicine approach for addressing COVID-19.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=103931479

Driver: Increasing government funding for cell based research

Researchers utilize isolated cells to understand their biology and develop new cell therapies and other cell-based treatments. Various government bodies across the globe have increased their support for the growth of such research activities, owing to its importance. For instance, in January 2016, the Federal Government of Canada granted USD 20 million to the Centre for Commercialization of Regenerative Medicine. This grant will be utilized for establishing a stem-cell therapy development facility in Toronto, Canada. In addition, NIH funding for the development of cell therapies has increased significantly over the last few years. This, in turn, is stimulating the demand for equipment, media, reagents, and accessories used in cell isolation research.

Restraint: cost of cell- based research

Cell biology involves extensive research on the development of new therapies such as stem cell and gene therapies. The instruments, reagents, and other products associated with this research are required to be of high quality in order to obtain accurate results. Owing to the need to maintain high-quality standards and comply with guidelines set up by regulatory authorities, the cost of research in cell biology is high. In addition, the success rate of cell-based research is very limited, and most cell therapy trials have a low success rate.

Recent Developments in the Global Cell Isolation Market:

# In May 2019, Thermo Fisher Scientific acquired Brammer Bio with the aim to expand capabilities to support the high growth gene and cell therapy market.
# In October 2018, Merck opened its M Lab Collaboration Center in São Paulo
# In May 2019, Beckman Coulter launched ClearLLab 10C System

Geographical Growth Segmentation:

In 2019, biotechnology and biopharmaceutical companies segment accounted for the largest share in the market, by end user

The cell isolation market is segmented into hospitals and diagnostic laboratories, biotechnology and biopharmaceutical companies, research laboratories and institutes, and other end users based on end users. In 2019, the biotechnology and biopharmaceutical companies segment accounted for the largest share. The large share of this end-user segment can be attributed to the widespread adoption of advanced instruments in cell-based experiments and cancer research in biotechnology and biopharmaceutical companies, as well as the increasing number of R&D facilities globally.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=103931479
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Makarand Vaidya
Country United States
Categories Biotech , Industry , Research
Tags advanced cell isolation techniques , cell isolation , cell isolation market
Last Updated July 4, 2022